Patent · US Active

Compositions, methods and uses for treating post-traumatic stress disorder

US11426444B2 · kind B2 · utility

0Cited by

0References

6Claims

0Family size

Inventors

David Lovejoy · Stouffville, CA
Robert B. Stein · Rydal, US
Andrew Slee · Averill Park, US
Garo Armen · New York, US

Key dates

Filing date	Oct 12, 2018
Grant date	Aug 30, 2022
Priority date	—
Expiry date	Oct 12, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/22
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions comprising a Teneurin C-terminal Associated Peptide—1 (TCAP-1) peptide are described with respect to methods and uses of same for preventing and/or treating post-traumatic stress disorder (“PTSD”).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.